Related references
Note: Only part of the references are listed.MDM4 polymorphisms associated with the risk but not the prognosis of esophageal cancer in Cixian high-incidence region from northern China
Rongmiao Zhou et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2022)
The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis
Jian Chen et al.
MEDICAL SCIENCE MONITOR (2022)
In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size
Nivas Shyamala et al.
SCIENTIFIC REPORTS (2022)
SNPs in Sites for DNA Methylation, Transcription Factor Binding, and miRNA Targets Leading to Allele-Specific Gene Expression and Contributing to Complex Disease Risk: A Systematic Review
Manik Vohra et al.
PUBLIC HEALTH GENOMICS (2021)
MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53
Xiaochen Zhang et al.
ANTICANCER RESEARCH (2021)
MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53
Alyssa M. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers
Corina Lesseur et al.
PLOS GENETICS (2021)
Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer
Agne Bartnykaite et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
Zaira Spinello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
Abdullah Alatawi et al.
JOURNAL OF SKIN CANCER (2021)
Five MDM4 gene polymorphisms on cancer risk: An updated systematic review and meta-analysis
Yaxuan Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2021)
The role of miRNAs in MDMX-p53 interplay
Dehua Yu et al.
JOURNAL OF EVIDENCE BASED MEDICINE (2021)
New developments on the Encyclopedia of DNA Elements (ENCODE) data portal
Yunhai Luo et al.
NUCLEIC ACIDS RESEARCH (2020)
Combined Effect of HPV and Several Gene SNPs in Laryngeal Cancer
Ausra Stumbryte-Kaminskiene et al.
MEDICINA-LITHUANIA (2020)
Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
De-Hua Yu et al.
FRONTIERS IN ONCOLOGY (2020)
SNPnexus: a web server for functional annotation of human genome sequence variation (2020 update)
Jorge Oscanoa et al.
NUCLEIC ACIDS RESEARCH (2020)
Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population
Nevena Kotarac et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Association of MDM4 Gene rs4245739 Polymorphism with the Risk and Clinical Characteristics of Colorectal Cancer in a Chinese Han Population
De-Ming Zhao et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2020)
Association of rs11801299 and rs1380576 polymorphisms at MDM4 with risk, clinicopathological features and prognosis in patients with retinoblastoma
Fenghua Yu et al.
CANCER EPIDEMIOLOGY (2019)
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in caucasian breast cancer patients
Marcus Bauer et al.
Oncotarget (2019)
A genetic variant within MDM4 3′UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer
Yang Zhang et al.
MOLECULAR CARCINOGENESIS (2019)
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
Chong Gao et al.
BREAST CANCER RESEARCH (2019)
Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx
Zhongming Lu et al.
MOLECULAR CARCINOGENESIS (2018)
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions
Dimitra Karagkouni et al.
NUCLEIC ACIDS RESEARCH (2018)
Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer
Ausra Stumbryte et al.
ONCOTARGET (2018)
Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample
Mohammad Hashemi et al.
CLINICAL BREAST CANCER (2018)
MDM4 contributes to the increased risk of glioma susceptibility in Han Chinese population
Peng Sun et al.
SCIENTIFIC REPORTS (2018)
Conditional eQTL analysis reveals allelic heterogeneity of gene expression
Rick Jansen et al.
HUMAN MOLECULAR GENETICS (2017)
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
Beatrice S. Melin et al.
NATURE GENETICS (2017)
Anatomy of Mdm2 and Mdm4 in evolution
Ban Xiong Tan et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2017)
MDM4 genetic variants and risk of gastric cancer in an eastern chinese population
Meng-Yun Wang et al.
ONCOTARGET (2017)
Single nucleotide polymorphisms and cancer susceptibility
Na Deng et al.
ONCOTARGET (2017)
Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs
Sumadi Lukman Anwar et al.
CANCER BIOLOGY & MEDICINE (2017)
The role of MDM4 SNP34091 A>C polymorphism in cancer: a meta-analysis on 19,328 patients and 51,058 controls
Xin Jin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth
Michael Dewaele et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility
Negar Pedram et al.
CLINICAL LABORATORY (2016)
The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer
Liv B. Gansmo et al.
TUMOR BIOLOGY (2016)
Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy
Yang Yang et al.
Oncotarget (2016)
Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer
Wendy M. Swetzig et al.
ONCOTARGET (2016)
LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants
Mitchell J. Machiela et al.
BIOINFORMATICS (2015)
A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer
Shane Stegeman et al.
ENDOCRINE-RELATED CANCER (2015)
A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer
Feng Gao et al.
PLOS ONE (2015)
MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk
Liv B. Gansmo et al.
CANCER MEDICINE (2015)
Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population
Guo-cong Wu et al.
MEDICAL ONCOLOGY (2015)
Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity
B. Bardot et al.
ONCOGENE (2015)
Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial
V. Le Morvan et al.
PHARMACOGENOMICS JOURNAL (2015)
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Kristen S. Purrington et al.
CARCINOGENESIS (2014)
Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations
Qiong Yu et al.
DIAGNOSTIC PATHOLOGY (2014)
Natural variation of histone modification and its impact on gene expression in the rat genome
Carola Rintisch et al.
GENOME RESEARCH (2014)
Role of the functional variant (-652T>G) in the XRCC4 promoter in prostate cancer
Ning Shao et al.
MOLECULAR BIOLOGY REPORTS (2014)
HDMX Folds the Nascent p53 mRNA following Activation by the ATM Kinase
Laurence Malbert-Colas et al.
MOLECULAR CELL (2014)
MDM4 Overexpressed in Acute Myeloid Leukemia Patients with Complex Karyotype and Wild-Type TP53
Li Li et al.
PLOS ONE (2014)
microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network
Yonit Hoffman et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility
Jibing Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery
Marco Bezzi et al.
GENES & DEVELOPMENT (2013)
Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Montserrat Garcia-Closas et al.
NATURE GENETICS (2013)
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Rosalind A. Eeles et al.
NATURE GENETICS (2013)
Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell Carcinoma
Liqing Zhou et al.
PLOS ONE (2013)
Stress-Induced Isoforms of MDM2 and MDM4 Correlate with High-Grade Disease and an Altered Splicing Network in Pediatric Rhabdomyosarcoma
Aishwarya G. Jacob et al.
NEOPLASIA (2013)
Modifying effect of MDM4 variants on risk of HPV16-associated squamous cell carcinoma of oropharynx
Hongping Yu et al.
CANCER (2012)
Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
Kristiaan Lenos et al.
CANCER RESEARCH (2012)
S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia
Ling Liu et al.
CANCER SCIENCE (2012)
Mdm2 and MdmX partner to regulate p53
Xinjiang Wang et al.
FEBS LETTERS (2012)
Combined p53-related genetic variants together with HPV infection increase oral cancer risk
Zhongqiu Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
SIFT web server: predicting effects of amino acid substitutions on proteins
Ngak-Leng Sim et al.
NUCLEIC ACIDS RESEARCH (2012)
Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma
Adriana Helena de Oliveira Reis et al.
PEDIATRIC BLOOD & CANCER (2012)
Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck
Hongping Yu et al.
PHARMACOGENETICS AND GENOMICS (2011)
A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma
Hong Fan et al.
BMC MEDICINE (2010)
An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity
Jessika Wynendaele et al.
CANCER RESEARCH (2010)
Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4
Shunbin Xiong et al.
CANCER RESEARCH (2010)
Single-Nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population
Tong Sun et al.
CLINICAL CANCER RESEARCH (2010)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
Shenying Fang et al.
PLOS ONE (2010)
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer
Diptee A. Kulkarni et al.
CARCINOGENESIS (2009)
Mitochondrial MDM4 (MDMX) An unpredicted role in the p53-mediated intrinsic apoptotic pathway
Francesca Mancini et al.
CELL CYCLE (2009)
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
Koji Okamoto et al.
FEBS LETTERS (2009)
Biogenesis of small RNAs in animals
V. Narry Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene
Gurinder Singh Atwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mutation analysis of the MDM4 gene in German breast cancer patients
Scarlett Reincke et al.
BMC CANCER (2008)
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties
Andrea Prodosmo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Linkage disequilibrium - understanding the evolutionary past and mapping the medical future
Montgomery Slatkin
NATURE REVIEWS GENETICS (2008)
MDMX promotes proteasomal turnover of p2l at G1 and early S phases independently of, but in cooperation with, MDM2
Yetao Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4
Dawn S. Chandler et al.
CANCER RESEARCH (2006)
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network
F Toledo et al.
CANCER CELL (2006)
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
S Francoz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis
F Bartel et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Identification of an aberrantly spliced form of HDMX in human tumors: A new mechanism for HDM2 stabilization
S Giglio et al.
CANCER RESEARCH (2005)
Regulation of p53-MDMX interaction by casein kinase 1 alpha
LH Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity
D Danovi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2
P de Graaf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells
R Rallapalli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Association study designs for complex diseases
LR Cardon et al.
NATURE REVIEWS GENETICS (2001)
Share Paper
